These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


198 related items for PubMed ID: 19276623

  • 21. The emergency department: first line of defense in preventing secondary stroke.
    Ovbiagele B.
    Acad Emerg Med; 2006 Feb; 13(2):215-22. PubMed ID: 16436789
    [Abstract] [Full Text] [Related]

  • 22. Persistent use of evidence-based pharmacotherapy in heart failure is associated with improved outcomes.
    Gislason GH, Rasmussen JN, Abildstrom SZ, Schramm TK, Hansen ML, Buch P, Sørensen R, Folke F, Gadsbøll N, Rasmussen S, Køber L, Madsen M, Torp-Pedersen C.
    Circulation; 2007 Aug 14; 116(7):737-44. PubMed ID: 17646585
    [Abstract] [Full Text] [Related]

  • 23. Pulse pressure--independent predictor of poor early outcome and mortality following ischemic stroke.
    Grabska K, Niewada M, Sarzyńska-Długosz I, Kamiński B, Członkowska A.
    Cerebrovasc Dis; 2009 Aug 14; 27(2):187-92. PubMed ID: 19092241
    [Abstract] [Full Text] [Related]

  • 24. [Transient ischemic attack, a medical emergency].
    Uchiyama S.
    Brain Nerve; 2009 Sep 14; 61(9):1013-22. PubMed ID: 19803400
    [Abstract] [Full Text] [Related]

  • 25. [Prognosis at six months for coronary patients: impact of antiplatelet agents and statins].
    Ferrières J, Cambou JP, Cantet C, Guize L.
    Ann Cardiol Angeiol (Paris); 2005 Dec 14; 54 Suppl 1():S10-6. PubMed ID: 16411646
    [Abstract] [Full Text] [Related]

  • 26. Clinical benefit of early reperfusion therapy in patients with ST-elevation myocardial infarction usually excluded from randomized clinical trials (results from the Maximal Individual Therapy in Acute Myocardial Infarction Plus [MITRA Plus] registry).
    Koeth O, Zahn R, Gitt AK, Bauer T, Juenger C, Senges J, Zeymer U, Maximal Individual Therapy in Acute Myocardial Infarction Plus Study Group.
    Am J Cardiol; 2009 Oct 15; 104(8):1074-7. PubMed ID: 19801027
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Efficacy of drug therapy in the secondary prevention of cardiovascular disease and stroke.
    Fletcher GF, Bufalino V, Costa F, Goldstein LB, Jones D, Smaha L, Smith SC, Stone N.
    Am J Cardiol; 2007 Mar 27; 99(6C):1E-35E. PubMed ID: 17378996
    [No Abstract] [Full Text] [Related]

  • 35. Effect of beta blockers, angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, and statins on mortality in patients with implantable cardioverter-defibrillators.
    Lai HM, Aronow WS, Kruger A, Desai H, Amin H, Frishman WH, Cohen M, Sorbera C.
    Am J Cardiol; 2008 Jul 01; 102(1):77-8. PubMed ID: 18572039
    [Abstract] [Full Text] [Related]

  • 36. Early hospital arrival improves outcome at discharge in ischemic but not hemorrhagic stroke: a prospective multicenter study.
    Naganuma M, Toyoda K, Nonogi H, Yokota C, Koga M, Yokoyama H, Okayama A, Naritomi H, Minematsu K.
    Cerebrovasc Dis; 2009 Jul 01; 28(1):33-8. PubMed ID: 19420920
    [Abstract] [Full Text] [Related]

  • 37. Prediction of functional outcome of ischemic stroke patients in northwest China.
    Liu X, Lv Y, Wang B, Zhao G, Yan Y, Xu D.
    Clin Neurol Neurosurg; 2007 Sep 01; 109(7):571-7. PubMed ID: 17600616
    [Abstract] [Full Text] [Related]

  • 38. Tracking trends in secondary stroke prevention strategies.
    Carswell JL, Beard KA, Chevrette MM, Pardue CN, Hess DC, Fagan SC.
    Ann Pharmacother; 2004 Feb 01; 38(2):215-9. PubMed ID: 14742753
    [Abstract] [Full Text] [Related]

  • 39. The Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischemic strOke or tRansient ischeMic attack (PERFORM) study: baseline characteristics of the population.
    Bousser MG, Amarenco P, Chamorro A, Fisher M, Ford I, Fox K, Hennerici M, Mattle HP, Rothwell PM, PERFORM Study Investigators.
    Cerebrovasc Dis; 2009 Feb 01; 27(6):608-13. PubMed ID: 19407444
    [Abstract] [Full Text] [Related]

  • 40. [Warning symptom TIA--role of the general practitioner].
    Schellinger PD.
    MMW Fortschr Med; 2008 May 19; 150 Suppl 2():25-6, 28. PubMed ID: 18678047
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 10.